- $116.26m
- $145.26m
- $94.64m
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview
Marketing Agreement Designed To Promote Complementary CDMO, API Manufacturing Services To Drug Developers
Brief: Societal CDMO Q3 Revenue USD 23.59 Million Vs. IBES Estimate USD 24.2 Million
Brief: Societal Cdmo Announces Corporate Restructuring
Brief: Societal Cdmo Secures Project Expansion Agreements With Several Existing Customers
U.S. STOCKS ON THE MOVE-Futu Holdings, Build-A-Bear Workshop, Copper miners
U.S. STOCKS ON THE MOVE-Medtronic, Futu Holdings, Align Tech
U.S. STOCKS ON THE MOVE-SharkNinja, Nvidia, Autodesk
U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Dollar Tree
Societal CDMO slides on proposed public offering
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Brief: Societal CDMO, Inc. Q2 revenue USD 21.799 million
Societal CDMO Inc reports results for the quarter ended in June - Earnings Summary
Societal CDMO Inc expected to post a loss of 3 cents a share - Earnings Preview
Societal CDMO Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Societal CDMO Selected By Spinnaker Biosciences To Execute CDMO Services In Support Of Co's Clinical Development Of A Novel Therapeutic Candidate